Neurocognitive problems among people with HIV – ranging from mild impairment that can only be detected with specialised tests to debilitating AIDS dementia – remain common in the era of effective antiretroviral treatment. [more]

At the XVIII International AIDS Conference, the Elizabeth Glaser Pediatric AIDS Foundation has issued the first phase of a series of three linked toolkits to facilitate the adaptation and implementation of the revised World Health Organization (WHO) recommendations in the following four technical areas: ARV drugs for treatment of pregnant women living with HIV and prevention of HIV infection in infants, infant and young child feeding in the context of HIV, antiretroviral therapy for HIV infectio...[more]

Nef proteins of primate lentiviruses, HIV-1, HIV-2 and SIV, are abundantly expressed in the early phase of HIV-1 infection and play a crucial role in the pathogenicity of HIV-1 and the development of AIDS.[more]

According to the World Health Organization (WHO), TB strains that are resistant to all major anti-TB drugs have been documented throughout every country on the globe.[more]

It has long been know that children who grow up on farms are less prone to allergies and allergic asthma.[more]

Silicosis is a well-recognized risk factor for tuberculosis (TB).[more]

Highly active antiretroviral therapy (HAART), currently known for its therapeutic benefits against HIV, has also been shown in a recent study published in the Lancet to reduce the spread of virus among people with a history of intravenous drug use[more]